A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole blood.

[1]  Y. Kodera,et al.  The impact of chronic Epstein–Barr virus infection on the liver graft of pediatric liver transplant recipients: A retrospective observational study , 2021, Transplant infectious disease : an official journal of the Transplantation Society.

[2]  S. Pergam,et al.  Dynamics of Epstein–Barr virus on post‐transplant lymphoproliferative disorders after antithymocyte globulin‐conditioned allogeneic hematopoietic cell transplant , 2021, Transplant infectious disease : an official journal of the Transplantation Society.

[3]  M. Mzibri,et al.  Circulating cell‐free epstein–barr virus DNA levels and clinical features in Moroccan patients with nasopharyngeal carcinoma , 2021, Infectious agents and cancer.

[4]  J. Preiksaitis,et al.  Post‐transplant lymphoproliferative disorders, Epstein‐Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice , 2019, Clinical transplantation.

[5]  A. Rickinson,et al.  The Global Landscape of EBV-Associated Tumors , 2019, Front. Oncol..

[6]  K. Nichols,et al.  Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. , 2019, Blood.

[7]  Y. Kwong,et al.  EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment , 2019, Front. Oncol..

[8]  A. Mocroft,et al.  The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients , 2018, Journal of Cancer Research and Clinical Oncology.

[9]  A. King,et al.  Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer , 2017, The New England journal of medicine.

[10]  M. Baccard,et al.  Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000–2016 , 2017, PloS one.

[11]  P. Ljungman,et al.  Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines , 2016, Haematologica.

[12]  A. Massie,et al.  The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. , 2016, Blood.

[13]  David Moher,et al.  STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies , 2015, BMJ : British Medical Journal.

[14]  A. Pang,et al.  Quantification of circulating Epstein–Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance , 2014, Leukemia.

[15]  H. Balfour,et al.  Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. , 2013, The Journal of infectious diseases.

[16]  P. Saas,et al.  Subclinical Epstein–Barr Virus Viremia Among Adult Renal Transplant Recipients: Incidence and Consequences , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  V. Anttila,et al.  Clinical characteristics, outcome and the role of viral load in nontransplant patients with Epstein-Barr viraemia. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  S. Hamilton-Dutoit,et al.  Characteristics of Hodgkin's lymphoma after infectious mononucleosis. , 2003, The New England journal of medicine.

[19]  A. Osterhaus,et al.  Diagnosing Herpesvirus Infections by Real-Time Amplification and Rapid Culture , 2003, Journal of Clinical Microbiology.

[20]  A. Osterhaus,et al.  Development of a Real-Time Quantitative Assay for Detection of Epstein-Barr Virus , 2000, Journal of Clinical Microbiology.

[21]  M. Epstein,et al.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.

[22]  V. Miller,et al.  Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. Sullivan,et al.  Infectious mononucleosis. , 2010, The New England journal of medicine.